Triple-Negative Breast Carcinoma — Trials

Triple-Negative Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

948 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 416
Recruiting: 234
Ph III recruiting: 21
Growth YoY: +2.4%
Industry share: 31%
Top sponsor: Fudan University
Termination share: 47%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (167)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03799679	Albumin-Bound Paclitaxel Followed by Epirubicin in Combination With Cyclophosphamide in Triple Negative Breast Cancer	unknown	Phase 4	60	Fudan UniversityOTHER	1	Jan 10, 2019	clinicaltrials
NCT02615457	Huaier Granule in Treating Women With Triple Negative Breast Cancer	unknown	Phase 4	300	Shandong UniversityOTHER	1	Nov 26, 2015	clinicaltrials